Infection and Immunity · 1992 · 91 citations · 14 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdverse Events Following ImmunizationClinical Vaccine TrialsVaccinationVaccine EffectivenessVaccine EfficacyVaccine SafetyAntitoxin ImmunityAntitoxin ReactionsComparative Vaccine SafetyCrossover DesignationEfficacy Against InfectionOral VaccinationOverall Vaccine EffectivenessReplicate Crossover Study Design
We conducted a double-blind, placebo-controlled, randomized crossover study to evaluate the safety and immunogenicity of a single 5 x 10(8)-CFU dose of live oral recombinant cholera vaccine CVD 103-HgR in 94 North American adults. The vaccine was well tolerated without associated adverse reactions. Despite minimal fecal excretion of vaccine, 97% of subjects exhibited serum vibriocidal antibody and 72% had antitoxin responses.
14
Carol O. Tacket, Genevieve Losonsky, James P. Nataro et al. · The Journal of Infectious Diseases · 1992 · 144 citations
Pisit Su-Arehawaratana, Preecha Singharaj, David N. Taylor et al. · The Journal of Infectious Diseases · 1992 · 118 citations